(Press-News.org) An innovative stem cell-based treatment for Type 1 diabetes can meaningfully regulate blood glucose levels and reduce dependence on daily insulin injections, according to new clinical trial results from the University of British Columbia (UBC) and Vancouver Coastal Health (VCH).
“This is a significant step toward a functional cure for Type 1 diabetes,” said Dr. David Thompson, principal investigator at the Vancouver trial site, clinical professor of endocrinology at UBC and director of the Vancouver General Hospital Diabetes Centre. “For the first time, a stem cell-based device can reduce the amount of insulin required for some trial participants with Type 1 diabetes. With further refinement of this approach, it’s only a matter of time until we have a therapy that can eliminate the need for daily insulin injections entirely.”
The findings, published today in Nature Biotechnology, arise from a multicenter clinical trial for an experimental cell therapy developed by U.S. biotechnology company ViaCyte (acquired by Vertex Pharmaceuticals) that is being clinically tested in Canada.
The therapy aims to replace the insulin-producing beta cells that people with Type 1 diabetes lack. Dubbed VC-02, the small medical implant contains millions of lab-grown pancreatic islet cells, including beta cells, that originate from a line of pluripotent stem cells.
The devices — approximately the size of a Band-Aid and no thicker than a credit card — are implanted just beneath a patient’s skin where it is hoped they will provide a steady, long-term regulated supply of self-sustaining insulin.
“Each device is like a miniature insulin-producing factory,” said co-author Dr. Timothy Kieffer, a professor within the departments of surgery and cellular and physiological sciences at UBC, and past chief scientific officer of ViaCyte. “The pancreatic islet cells, grown from stem cells, are packaged into the device to essentially recreate the blood sugar-regulating functions of a healthy pancreas. This may have tremendous benefits over transplant of scarcely available donor-derived cells, given that we can create a virtually limitless supply.”
The clinical trial was conducted at Vancouver General Hospital, with additional sites in Belgium and the U.S. Ten participants, each of whom had no detectable insulin production at the start of the study, underwent surgery to receive up to 10 device implants each.
Six months later, three participants showed significant markers of insulin production and maintained those levels throughout the remainder of the year-long study. These participants spent more time in an optimal blood glucose range and reduced their intake of externally administered insulin.
One participant, in particular, showed remarkable improvement, with time spent in the target blood glucose range increasing from 55 to 85 per cent, and a 44-per-cent reduction in their daily insulin administration.
The results are the latest in a series of clinical trials funded by Canada’s Stem Cell Network and conducted by the UBC-VCH team.
“The Stem Cell Network is delighted to support this clinical trial and we’re pleased to see the promising results,” said Cate Murray, president and CEO of the SCN. “Moving toward a functional cure for diabetes will require a coordinated and collaborative effort. It takes excellent science by top researchers in world-leading institutions, funders, like SCN, that de-risk research, and innovative biotech companies that can manufacture and scale the technology. SCN is proud to play its part and we look forward to what’s next in game-changing diabetes research.”
The trials aim to accelerate the development and clinical testing of novel stem-cell based therapies for the 300,000 Canadians living with Type 1 diabetes. Diabetes is estimated to cost the Canadian health-care system $29 billion annually.
Previously, in a 2021 study in Cell Stem Cell, the researchers were the first to show that the approach could produce insulin in the human body. The latest trial sought to significantly increase the amount of insulin produced by leveraging two-to-three times more devices per participant, alongside an updated device design with small perforations to allow for blood vessel ingrowth — a feature aimed at improving survival of the lab-grown cells.
In another ongoing trial, the UBC-VCH team is investigating whether a version of the device containing cells that have been genetically engineered to evade the immune system, using CRISPR gene-editing technology, could eliminate the need for participants to take immunosuppressant drugs alongside the treatment.
“We envision a future where people with Type 1 diabetes are able to live their lives free from daily insulin injections and free from immune-suppressing drugs,” said Dr. Thompson. “That future is now within reach, and Canada is leading the way in efforts to bring these novel treatments to patients.”
These trials are continuing to recruit participants. People who are interested in participating and want to learn more can contact study coordinator Barbara Allan (barbara.allan@vch.ca).
Interview language(s): English
END
Stem cell-based treatment controls blood sugar in people with Type 1 diabetes
2023-11-27
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Wave Devouring Propulsion: a revolutionary green technology for maritime sustainability
2023-11-27
A new form of wave devouring propulsion (WDP) could power ships and help to cut greenhouse gas emissions in the maritime industry.
Academics from Cranfield University have worked on the concept of using wave energy for propulsion, and designed an inventive method of achieving greater thrust from the power of the waves by harnessing a vessel’s submerged flapping foils in an innovative way.
Inspiration from whale fins
Taking inspiration from the power of a whale's fins, the team studied the structure and movement of the tail fin to unravel how it effectively uses wave energy for propulsion. Through simulations and experiments, they developed ...
Algorithmic recommendation technology or human curation? Study of online news outlet in Germany suggests both
2023-11-27
Recommender systems are machine learning applications in online platforms that automate tasks historically done by people. In the news industry, recommender algorithms can assume the tasks of editors who select which news stories people see online, with the goal of increasing the number of clicks by users, but few studies have examined how the two compare.
A new study examined how users of an online news outlet in Germany reacted to automated recommendations versus choices made by human editors. On average, the algorithm outperformed the person, but the person did better under certain conditions. The study’s authors suggest a combination of human curation and automated recommender ...
BU study finds breast density discussions with clinicians varied significantly by race/ethnicity and literacy level
2023-11-27
(Boston)—Breast density information aims to increase awareness of breast density and its risks and inform future breast screening decisions. Breast density notifications (BDN) advise women to discuss breast density with their clinicians, but prior research shows less than half of women in the general population have those conversations and little is known about the content of conversations that do occur.
A new study by researchers from Boston University Chobanian & Avedisian School ...
Alien haze, cooked in a lab, clears view to distant water worlds
2023-11-27
Scientists have simulated conditions that allow hazy skies to form in water-rich exoplanets, a crucial step in determining how haziness muddles observations by ground and space telescopes.
The research offers new tools to study the atmospheric chemistry of exoplanets and will help scientists model how water exoplanets form and evolve, findings that could help in the search for life beyond our solar system.
“The big picture is whether there is life outside the solar system, but trying to answer that kind of question requires really detailed modeling of all different types, specifically in planets with lots of water,” said co-author ...
Deoxygenation levels similar to today’s played a major role in marine extinctions during major past climate change event
2023-11-27
Scientists have made a surprising discovery that sheds new light on the role that oceanic deoxygenation (anoxia) played in one of the most devastating extinction events in Earth’s history. Their finding has implications for current day ecosystems – and serves as a warning that marine environments are likely more fragile than apparent.
New research, published today in leading international journal Nature Geosciences, suggests that oceanic anoxia played an important role in ecosystem disruption and extinctions in marine environments during the Triassic–Jurassic mass extinction, ...
Fish IgM structure sheds light on antibody evolution, study finds
2023-11-27
Antibodies—proteins that are produced by our immune system to protect us—are crucial for recognizing and getting rid of unwanted substances, or antigens, in our body. Although their role is universal, antibody structure varies in different animals. In a new study, researchers have analyzed the antibody Immunoglobulin M in rainbow trout to shed some light on why these proteins may have evolved over time.
In humans, IgM consists of five repeating units that are held together by a joining chain, resulting in a star shape. Consequently, IgM can bind to multiple antigens at the ...
Wind and solar projects can profit from bitcoin mining
2023-11-27
ITHACA, N.Y. – Bitcoin mining is often perceived as environmentally damaging because it uses huge amounts of electricity to power its intensive computing needs, but a new study demonstrates how wind and solar projects can profit from bitcoin mining during the precommercial development phase — when a wind or solar farm is generating electricity, but has not yet been integrated into the grid.
The findings suggest some developers could recoup millions of dollars to potentially invest in future renewable energy projects.
The ...
Vampire bats make northward flight seeking stable climates
2023-11-27
Vampire bats may soon take up residence in the United States and bring with them an ancient pathogen.
“What we found was that the distribution of vampire bats has moved northward across time due to past climate change, which has corresponded with an increase in rabies cases in many Latin American countries,” said Paige Van de Vuurst, a Ph.D. student in Virginia Tech’s Translational Biology, Medicine, and Health Graduate Program.
Van de Vuurst is the lead author of research recently published in the Ecography journal that predicts ...
New method uses crowdsourced feedback to help train robots
2023-11-27
To teach an AI agent a new task, like how to open a kitchen cabinet, researchers often use reinforcement learning — a trial-and-error process where the agent is rewarded for taking actions that get it closer to the goal.
In many instances, a human expert must carefully design a reward function, which is an incentive mechanism that gives the agent motivation to explore. The human expert must iteratively update that reward function as the agent explores and tries different actions. This can be time-consuming, inefficient, ...
Study shows price discounts on healthful foods like vegetables and zero-calorie beverages lead to an increase in consumption of these foods
2023-11-27
Dietary food intake has a major influence on health indicators, including Body Mass Index (BMI), blood pressure, serum cholesterol and glucose. Previous research has shown that decisions to purchase specific food items are primarily based on taste and cost. In the United States, only 12 percent and 10 percent of adults meet fruit and vegetable intake recommendations, respectively. Since affordability of food items is a limiting factor for meeting fruit and vegetable intake guidelines, researchers hypothesize that more affordable low energy-dense foods like fruits and vegetables, which are relatively more expensive ...